Virios Therapeutics annual meeting elects all six director nominees, ratifies FORVIS as auditor

Dogwood Therapeutics, Inc.

Quorum of 8,699,494 shares (45.17% of voting power) present at June 18, 2024 meeting.
All six director nominees elected: Burch (3,201,273 for), De La Rosa (2,440,247), Duncan (3,183,237), Keefer (3,198,840), Thomas (3,201,528), Whitley (1,964,627).
Highest withheld votes were for Dr. Whitley with 1,442,138 withheld.
Ratification of FORVIS LLP as auditor for FY2024 approved with 8,347,686 for, 241,056 against, 110,752 abstain.
No broker non-votes on auditor ratification; broker non-votes of 5,292,729 on director elections.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.